Stephanie Mgebroff

2.3k total citations · 2 hit papers
24 papers, 1.7k citations indexed

About

Stephanie Mgebroff is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, Stephanie Mgebroff has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 6 papers in Immunology and 3 papers in Biomedical Engineering. Recurrent topics in Stephanie Mgebroff's work include CAR-T cell therapy research (21 papers), Biosimilars and Bioanalytical Methods (3 papers) and Nanowire Synthesis and Applications (3 papers). Stephanie Mgebroff is often cited by papers focused on CAR-T cell therapy research (21 papers), Biosimilars and Bioanalytical Methods (3 papers) and Nanowire Synthesis and Applications (3 papers). Stephanie Mgebroff collaborates with scholars based in United States, Switzerland and Canada. Stephanie Mgebroff's co-authors include Ivan Borrello, Kimberly Noonan, Paolo Serafini, Julie R. Park, Michael C. Jensen, Catherine Lindgren, Colleen Annesley, Christopher Brown, Olivia Finney and Corinne Summers and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Stephanie Mgebroff

24 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults

2017 787 citations Rebecca Gardner, Olivia Finney et al. Blood profile →
Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells

2008 557 citations Paolo Serafini, Stephanie Mgebroff et al. Cancer Research profile →

Peers

Countries citing papers authored by Stephanie Mgebroff

Since Specialization

Citations

This map shows the geographic impact of Stephanie Mgebroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Mgebroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Mgebroff more than expected).

Fields of papers citing papers by Stephanie Mgebroff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Mgebroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Mgebroff. The network helps show where Stephanie Mgebroff may publish in the future.

Co-authorship network of co-authors of Stephanie Mgebroff

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Mgebroff. A scholar is included among the top collaborators of Stephanie Mgebroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Mgebroff. Stephanie Mgebroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of PLAT-02 and PLAT-03: Evaluating CD19 CAR T-Cell Therapy and CD19-expressing T-APC Support in Pediatric B-ALL 2025 ·Blood ·Colleen Annesley, Kristy Seidel, Qian Wu, Corinne Summers, Alan S. Wayne, Michael A. Pulsipher, Anurag K. Agrawal, Christopher T. Brown, Stephanie Mgebroff, Catherine Lindgren, Stephanie Rawlings-Rhea, Wenjun Huang, (unknown), Michael C. Jensen, Julie R. Park, Rebecca Gardner	2
2	Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALL 2024 ·Blood Advances ·Colleen Annesley, Adam J. Lamble, Corinne Summers, Michael A. Pulsipher, Alan S. Wayne, Julie Rivers, Wenjun Huang, (unknown), Qian Wu, Kristy Seidel, Stephanie Mgebroff, Christopher T. Brown, Catherine Lindgren, Julie R. Park, Michael C. Jensen, Rebecca Gardner	2
3	STRIvE-02 Arm C: Phase 1 study of concurrent PD-1 inhibition with B7-H3 CAR T cell immunotherapy for recurrent/refractory pediatric solid tumors. 2024 ·Journal of Clinical Oncology ·Michelle Choe, Mallory Taylor, Jason Wendler, (unknown), Stephanie Rawlings-Rhea, Kristy Seidel, Wenjun Huang, Sowmya Pattabhi, (unknown), On Ho, Ashley Wilson, Stephanie Mgebroff, Christopher Brown, Catherine Lindgren, Colleen Annesley, Rebecca Gardner, Michael C. Jensen, Julie R. Park, Catherine M. Albert, Navin Pinto	1
4	ENLIGHten-01: A phase 1 study of fluorescein-specific (FITC-E2)-CAR T cells in combination with folate-fluorescein (UB-TT170) for osteosarcoma. 2023 ·Journal of Clinical Oncology ·Catherine M. Albert, Navin Pinto, Mallory Taylor, Ashley Wilson, Stephanie Rawlings-Rhea, Wenjun Huang, Kristy Seidel, (unknown), Stephanie Mgebroff, Christopher Brown, Jacob Garcia, (unknown), Rebecca Gardner, Rimas J. Orentas, Michael C. Jensen, Julie R. Park	4
5	Effect of bispecific B7H3 x CD19 CAR T cells on host CD19 expression and CAR T cell engraftment. 2023 ·Journal of Clinical Oncology ·Navin Pinto, Catherine M. Albert, Mallory Taylor, Ashley Wilson, Stephanie Rawlings-Rhea, Wenjun Huang, Kristy Seidel, (unknown), Vicky Wu, Stephanie Mgebroff, Christopher Brown, Nicholas A. Vitanza, Rebecca Gardner, Michael C. Jensen, Julie R. Park	2
6	Modified Manufacturing Process Modulates CD19CAR T-cell Engraftment Fitness and Leukemia-Free Survival in Pediatric and Young Adult Subjects 2022 ·Cancer Immunology Research ·Francesco Ceppi, Ashley Wilson, Colleen Annesley, (unknown), Corinne Summers, Adam Brand, Kristy Seidel, Qian Wu, (unknown), Christopher Brown, Stephanie Mgebroff, Catherine Lindgren, Stephanie Rawlings-Rhea, Wenjun Huang, Michael A. Pulsipher, Alan S. Wayne, Julie R. Park, Michael C. Jensen, Rebecca Gardner	14
7	Pediatric and young adult leukemia adoptive therapy (PLAT)-08: A phase 1 study of SC-DARIC33 in pediatric and young adults with relapsed or refractory CD33+ AML. 2022 ·Journal of Clinical Oncology ·Todd M. Cooper, Vicky Wu, Ashley Wilson, Jacob Appelbaum, Jordan Jarjour, Joshua D. Gustafson, Stephanie Mgebroff, Catherine Lindgren, Christopher A. Brown, Michael C. Jensen, Julie R. Park, Rebecca Gardner	6
8	SCRI-CAR19x22v2 T Cell Product Demonstrates Bispecific Activity in B-ALL 2021 ·Blood ·Colleen Annesley, Corinne Summers, Michael A. Pulsipher, Jodi Skiles, Amanda M. Li, Anant Vatsayan, Catherine Lindgren, Stephanie Mgebroff, Ashley Wilson, Wenjun Huang, Qian Wu, Joshua D. Gustafson, (unknown), Michael C. Jensen, Julie R. Park, Rebecca Gardner	16
9	Efficacy of SCRI-CAR19x22 T cell product in B-ALL and persistence of anti-CD22 activity. 2020 ·Journal of Clinical Oncology ·Rebecca Gardner, Colleen Annesley, Ashley Wilson, Corinne Summers, (unknown), Vicky Wu, Wenjun Huang, Adam Johnson, Amanda Li, Kirk R. Schultz, Catherine Lindgren, Stephanie Mgebroff, Christopher Brown, Julie R. Park, Michael C. Jensen	10
10	Clinical Experience of CAR T Cell Immunotherapy for Relapsed and Refractory Infant ALL Demonstrates Feasibility and Favorable Responses 2019 ·Blood ·Colleen Annesley, Corinne Summers, Michael A. Pulsipher, Alan S. Wayne, Julie Rivers, Adam J. Lamble, Ashley Wilson, Qian Wu, Adam Brand, Stephanie Mgebroff, Christopher Brown, Catherine Lindgren, Julie R. Park, Michael C. Jensen, Rebecca Gardner	11
11	Novel CD19t T-Antigen Presenting Cells Expand CD19 CAR T Cells In Vivo 2019 ·Blood ·Colleen Annesley, Rebecca Gardner, Ashley Wilson, Corinne Summers, Adam J. Lamble, Julie Rivers, Qian Wu, Adam Brand, Adam Johnson, (unknown), Stephanie Mgebroff, Christopher Brown, Catherine Lindgren, Julie R. Park, Michael C. Jensen	16
12	Manufacture of Chimeric Antigen Receptor T Cells from Mobilized Cyropreserved Peripheral Blood Stem Cell Units Depends on Monocyte Depletion 2018 ·Biology of Blood and Marrow Transplantation ·Annette Künkele, Christopher Brown, (unknown), Stephanie Mgebroff, Adam Johnson, Agne Taraseviciute, Lisa S. Rolczynski, Cindy A. Chang, Olivia Finney, Julie R. Park, Michael C. Jensen	23
13	Lymphocyte apheresis for chimeric antigen receptor T‐cell manufacturing in children and young adults with leukemia and neuroblastoma 2018 ·Transfusion ·Francesco Ceppi, Julie Rivers, Colleen Annesley, Navin Pinto, Julie R. Park, Catherine Lindgren, Stephanie Mgebroff, (unknown), Meghan Delaney, Rebecca Gardner	71
14	Novel CD19t T-Antigen Presenting Cells Designed to Re-Activate and Expand CD19 CAR T Cells In Vivo: Early Demonstration of Feasibility and Safety 2018 ·Blood ·Colleen Annesley, Rebecca Gardner, Olivia Finney, Corinne Summers, Adam J. Lamble, Julie Rivers, Adam Johnson, (unknown), Stephanie Mgebroff, Christopher Brown, Catherine Lindgren, Julie R. Park, Michael C. Jensen	1
15	Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility 2016 ·Clinical Cancer Research ·Annette Künkele, Agne Taraseviciute, Laura S. Finn, Adam Johnson, Carolina Berger, Olivia Finney, Cindy A. Chang, Lisa S. Rolczynski, Christopher Brown, Stephanie Mgebroff, Michael Berger, Julie R. Park, Michael C. Jensen	75
16	CD19CAR T Cell Products of Defined CD4:CD8 Composition and Transgene Expression Show Prolonged Persistence and Durable MRD-Negative Remission in Pediatric and Young Adult B-Cell ALL 2016 ·Blood ·Rebecca Gardner, Olivia Finney, Hannah Smithers, Kasey J. Leger, Colleen Annesley, Corinne Summers, Christopher Brown, Stephanie Mgebroff, Catherine Lindgren, (unknown), Assaf P. Oron, D. Li, Marie Bleakley, Julie R. Park, Michael C. Jensen	31
17	T Cell Products of Defined CD4:CD8 Composition and Prescribed Levels of CD19CAR/Egfrt Transgene Expression Mediate Regression of Acute Lymphoblastic Leukemia in the Setting of Post-Allohsct Relapse 2014 ·Blood ·Rebecca Gardner, Julie R. Park, Karen S. Kelly‐Spratt, Olivia Finney, Hannah Smithers, Virginia J. Hoglund, Christopher Brown, Stephanie Mgebroff, Catherine Lindgren, Assaf P. Oron, Marie Bleakley, Michael C. Jensen	7
18	Myeloid-Derived Suppressor Cells Promote Cross-Tolerance in B-Cell Lymphoma by Expanding Regulatory T Cells breakdown → 2008 ·Cancer Research ·Paolo Serafini, Stephanie Mgebroff, Kimberly Noonan, Ivan Borrello	557
19	The Immunomodulatory Role of Lenalidomide on Prevnar® Responses in Patients with Relapsed Multiple Myeloma: A Comprehensive Analysis of the Immune Response 2008 ·Blood ·Kimberly Noonan, Anna Ferguson, Carol Ann Huff, (unknown), Stephanie Mgebroff, (unknown), Robert Knight, Ivan Borrello	9
20	Th-17 Lymphocytes, Not Regulatory T Cells, Mediate Immune Regulation of Bone Marrow Infiltrating Lymphocytes and Induce Osteoclast Activation in Multiple Myeloma. 2007 ·Blood ·Kimberly Noonan, (unknown), Stephanie Mgebroff, Paolo Serafini, David Roodman, Ivan Borrello	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact